Tag Archives: pharmaceutical industry

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. HOUSE PANEL TO VOTE ON BIPARTISAN DRUG PRICING MEASURE The House Ways and Means Committee is scheduled to vote Tuesday on legislation that contains several prescription drug pricing provisions, including requiring pharmacy benefit managers to disclose details … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices; bill introduction suspending medical device tax delayed; Grassley renews nursing home abuse inquiry; more committees hold more drug pricing hearings; and more.… Continue Reading

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • The House will take up H.R. 1, a broad measure addressing voting rights, campaign finance and government ethics laws. • Michael Cohen, the former attorney for President Donald Trump, continues his behind-closed-doors testimony at the House Intelligence … Continue Reading

Senate Democrats recently introduced the Stop Price Gouging Act

Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs. The bill generally requires a company to justify to the Department of Health and Human Services (DHHS) any spike in prescription drug prices, but it is … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more.… Continue Reading
LexBlog